{"name": "SAGE Therapeutics",
 "permalink": "sage-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/sage-therapeutics",
 "homepage_url": "http://www.sagerx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@sagerx.com",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Oct 19 02:49:20 UTC 2011",
 "updated_at": "Wed Oct 19 02:49:18 UTC 2011",
 "overview": "\u003Cp\u003ESAGE Therapeutics is dedicated to the health and wellbeing of patients with central nervous system (CNS) disorders. Our mission is to discover, develop and deliver novel medicines for many of today\u00e2\u20ac\u2122s most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0015/8645/158645v1-max-150x150.jpg"],
     [[180,
       60],
      "assets/images/resized/0015/8645/158645v1-max-250x250.jpg"],
     [[180,
       60],
      "assets/images/resized/0015/8645/158645v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Interim CEO",
    "person":
     {"first_name": "Kevin",
      "last_name": "Starr",
      "permalink": "kevin-starr-2",
      "image": null}},
   {"is_past": false,
    "title": "Interim CEO and Board Member ",
    "person":
     {"first_name": "Kevin",
      "last_name": "Starr",
      "permalink": "kevin-starr",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2011/10/sage-therapeutics-raises-35m-series-funding-rock-ventures.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "SAGE Therapeutics Raises $35M in Series A Funding from Third Rock Ventures",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Third Rock Ventures",
         "permalink": "third-rock-ventures-2",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0005/0700/50700v1-max-150x150.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-250x250.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "29 Newbury Street",
    "address2": "",
    "zip_code": "02116",
    "city": "Boston",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}